Gastrointestinal Archives - Page 3 Of 7

FRUZAQLA (fruquintinib) capsules

FRUZAQLA (fruquintinib) capsules, for oral use Initial U.S. Approval: 2023

FRUZAQLA is indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.

Brand Name:	FRUZAQLA
Generic Name:	fruquintinib
Strength:	Capsules: 1 mg and 5 mg
Manufacturer:	Takeda Pharmaceuticals America, Inc.
Approved By:	EMA, USFDA

Source Details: Patient Information

IPN, New Delhi can facilitate patient to import of “FRUZAQLA (fruquintinib) capsules” in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please email IPN healthcare Support Team for FRUZAQLA (fruquintinib) capsules price list or cost in India. on Mr. Tarun:- +91 9891 296 838 / Mr. Neeraj:- +91 9811 747 774.

futibatinib tablets

Gastrointestinal

futibatinib tablets
for oral use Initial U.S. Approval: YYYY

Lytgobi (futibatinib) is a kinase inhibitor indicated for the treatment of adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring fibroblast growth factor receptor 2 (FGFR2) gene fusions or other rearrangements. This medicine was approved by the FDA in the USA on 22 September 2022.

Facts about futibatinib) tablets

Approval Date: 9/30/2022
Proprietary Name: Lytgobi
Active Ingredient(s): futibatinib
DISEASE INDICATIONS-Bile Duct Cancer
MANUFACTURER-Taiho Pharmaceuticals
USAGE-Tablets: 4 mg
MEDICINE APPROVED BY-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “futibatinib) tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Gemcitabine for injection

Ovarian, Breast Cancer, Lung, Pancreatic

gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Gemcitabine hydrochloride is a type of chemotherapy called an antimetabolite. It kills cancer cells and other rapidly growing cells by preventing them from making DNA and RNA.

Facts about Gemcitabine for injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): Gemcitabine for injection
Dosage Forms And Strengths: Capsules: • 200 mg/single-use vial • 1 g/single-use vial
Company: Eli Lilly and Company
Current indications: non-small cell lung cancer; NSCLC
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Gemcitabine for injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

hydroxyurea capsules

Leukemia, Head And Neck

hydroxyurea capsules
for oral use Initial U.S. Approval: 1967

hydroxyurea capsules is an antimetabolite indicated for the treatment of: • Resistant chronic myeloid leukemia. • Locally advanced squamous cell carcinomas of the head and neck, (excluding lip) in combination with concurrent chemoradiation.

Facts about hydroxyurea capsules

Approval Date: 1967
Proprietary Name: On Request
Active Ingredient(s): hydroxyurea capsules
Dosage Forms And Strengths: Capsules: 500 mg
Company: Bristol-Myers Squibb
Current indications: chronic myeloid leukemia, head and neck
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import hydroxyurea capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

infigratinib capsules

Gastrointestinal

infigratinib capsules
for oral use Initial U.S. Approval: 2021

Truseltiq (infigratinib) is a prescription medicine used to treat previously-treated locally advanced or metastatic bile duct cancer (cholangiocarcinoma).

Facts about infigratinib capsules

Disease Indications-Bile Duct Cancer
Manufacturer-QED Therapeutics
Usage-Oral Capsules: 25 mg and 100 mg
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “infigratinib capsules” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

infliximab Injection

Arthritis, Ulcerative Colitis

infliximab Lyophilized Concentrate
for Injection, for Intravenous Use Initial U.S. Approval: 1998

Facts about infliximab Lyophilized Concentrate

Approval Date: 1998
Proprietary Name: On Request
Active Ingredient(s): infliximab
Dosage Forms And Strengths: For injection: 100 mg of infliximab as a lyophilized powder in a single-dose vial for reconstitution and dilution.
Company: Johnson & Johnson
Diseases: Chron’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “infliximab Lyophilized Concentrate ” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Ipilimumab Injection

Gastrointestinal, Skin

ipilimumab injection,
for intravenous use Initial U.S. Approval: 2011

Yervoy (ipilimumab) is a kinase inhibitor indicated for the treatment of advanced (unresectable or metastatic) melanoma.

Facts about Ipilimumab Injection

API: ipilimumab
Trade Name: On Request
Packaging: injection, for intravenous use
Strength: Injection: 50 mg/10 mL (5 mg/mL) and 200 mg/40 mL (5 mg/mL) in a single-use vial.
DISEASE INDICATIONS-Urothelial Carcinoma, Skin Cancer
MANUFACTURER-Bristol-Myers Squibb
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Pharmaceuticals and Medical Devices Agency (PMDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “Ipilimumab Injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

Irinotecan Injection

Colon

Irinotecan Injection
intravenous infusion Initial U.S. Approval: 1996

Irinotecan Injection is a topoisomerase inhibitor indicated for: • First-line therapy in combination with 5-fluorouracil and leucovorin for patients with metastatic carcinoma of the colon or rectum. • Patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial fluorouracil-based therapy.

Facts about Irinotecan Injection

Approval Date: 1996
Proprietary Name: On Request
Active Ingredient(s): Irinotecan Injection
Dosage Forms And Strengths: Available in three single-dose sizes: • 2 mL-fill vial containing 40 mg irinotecan hydrochloride injection • 5 mL-fill vial containing 100 mg irinotecan hydrochloride injection • 15 mL-fill vial containing 300 mg irinotecan hydrochloride injection
Company: Pfizer Inc
Current indications:
Medicine Approved By: – European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA approved use on approval date: Click Here

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import Irinotecan Injection” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

irinotecan liposome injection

Pancreatic

irinotecan liposome injection
for intravenous use Initial U.S. Approval: 1996

liposomal irinotecan is indicated in combination with 5-fluorouracil and leucovorin (two other cancer medicines for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.

Facts about irinotecan liposome injection

DISEASE INDICATIONS-Pancreatic Cancer
MANUFACTURER-Baxalta Innovations GmbH
USAGE-Intravenous
MEDICINE APPROVED BY-European Medical Agency (EMA), Food and Drug Administration (FDA), Health Canada, Therapeutic Goods Administration (TGA), Medsafe (NZ)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “irinotecan liposome injection tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

ivosidenib tablets

Leukemia, Gastrointestinal

ivosidenib tablets
for oral use Initial U.S. Approval: 2018

Tibosovo (ivosidenib) is a prescription medicine used to treat adults with an IDH1 mutation who have: Acute myeloid leukemia (AML) that is either newly-diagnosed or relapsed/refractory, or Locally advanced or metastatic bile duct cancer (cholangiocarcinoma).

Facts about ivosidenib tablets

Disease Indications-Leukemia, Bile Duct Cancer
Manufacturer-Agios Pharmaceuticals, Inc.
Usage-Oral
Medicine Approved By-Food and Drug Administration (FDA)
Summary of FDA-approved use on approval date: Click Here
(see Drugs@FDA for complete indication)

Access the best support services globally

If you have a prescription from a Registered Medical Practitioner (RMP), IPN in Delhi can assist you in obtaining access to genuine medication. Our professional will provide you with a step-by-step guide on how to legally and safely import “ivosidenib tablets” based on the information you provide.

Indian Pharma Network (IPN) Legitimate consultant and facilitator in the New Delhi, India. IPN has over two decades of industry experience and extensive coverage throughout India, including major cities such as Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, the North East, Pune, and other regions.

List of Oncology Medication For

Gastrointestinal

Indian Pharma Network

M: +9891296838 / 9811747774E: med@indianpharmanetwork.co.in

FRUZAQLA (fruquintinib) capsules, for oral use Initial U.S. Approval: 2023

futibatinib tablets for oral use Initial U.S. Approval: YYYY

Facts about futibatinib) tablets

Access the best support services globally

gemcitabine for injection Powder, Lyophilized, For Solution For Intravenous Use Initial U.S. Approval: 1996

Facts about Gemcitabine for injection

Access the best support services globally

hydroxyurea capsules for oral use Initial U.S. Approval: 1967

Facts about hydroxyurea capsules

Access the best support services globally

infigratinib capsules for oral use Initial U.S. Approval: 2021

Facts about infigratinib capsules

Access the best support services globally

infliximab Lyophilized Concentrate for Injection, for Intravenous Use Initial U.S. Approval: 1998

Facts about infliximab Lyophilized Concentrate

Access the best support services globally

ipilimumab injection, for intravenous use Initial U.S. Approval: 2011

Facts about Ipilimumab Injection

Access the best support services globally

Irinotecan Injection intravenous infusion Initial U.S. Approval: 1996

Facts about Irinotecan Injection

Access the best support services globally

irinotecan liposome injection for intravenous use Initial U.S. Approval: 1996

Facts about irinotecan liposome injection

Access the best support services globally

ivosidenib tablets for oral use Initial U.S. Approval: 2018

Facts about ivosidenib tablets

Access the best support services globally

Contact Info

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

M: +9891296838 / 9811747774
E: med@indianpharmanetwork.co.in

futibatinib tablets
for oral use Initial U.S. Approval: YYYY

hydroxyurea capsules
for oral use Initial U.S. Approval: 1967

infigratinib capsules
for oral use Initial U.S. Approval: 2021

infliximab Lyophilized Concentrate
for Injection, for Intravenous Use Initial U.S. Approval: 1998

ipilimumab injection,
for intravenous use Initial U.S. Approval: 2011

Irinotecan Injection
intravenous infusion Initial U.S. Approval: 1996

irinotecan liposome injection
for intravenous use Initial U.S. Approval: 1996

ivosidenib tablets
for oral use Initial U.S. Approval: 2018